Snow Lake Capital (Hk) LTD I Mab Transaction History

Snow Lake Capital (Hk) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$45.28 - $74.5 $53.9 Million - $88.7 Million	-1,190,737 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$27.46 - $47.03 $5.36 Million - $9.18 Million	-195,238 Reduced 14.09%	1,190,737 $56 Million
Q2 2020 Aug 14, 2020	BUY	$13.0 - $31.0 $1.89 Million - $4.5 Million	145,275 Added 11.71%	1,385,975 $41.5 Million
Q1 2020 May 15, 2020	BUY	$10.63 - $15.37 $13.2 Million - $19.1 Million	1,240,700 New	1,240,700 $16.1 Million

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.1M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Snow Lake Capital (Hk) LTD, based on Form 13F filings with the SEC.

Stay updated on Snow Lake Capital (Hk) LTD with notifications on news.